Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jeffrey J Sands, MD MMM
Fresenius Medical Care North America
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Avantus Renal Therapy-Saint Raphael Dialysis Center
New Haven, Connecticut, United States
- Irving Place Dialysis Center
New York, New York, United States
- Upper Manhattan Dialysis Clinic
New York, New York, United States
- Yorkville Dialysis Center
New York, New York, United States
- Davita Medical Center Houston
Houston, Texas, United States
- Davita Downtown Dialysis Clinic
San Antonio, Texas, United States
- Davita Northwest Medical Center
San Antonio, Texas, United States
- Davita Rivercenter Dialysis Clinic
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2009
- Primary completion
- 30 Jun 2010
- Completion
- 31 Oct 2010
- Last update posted
- 2 Sept 2011
- Registered enrollment
- 300
- Registry id
- NCT01092455
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.